Curcumin-derived carbon-dots as a potential COVID-19 antiviral drug

Even entering the third year of the COVID-19 pandemic, only a small number of COVID-19 antiviral drugs are approved. Curcumin has previously shown antiviral activity against SARS-CoV-2 nucleocapsid, but its poor bioavailability limits its clinical uses. Utilizing nanotechnology structures, curcumin-...

Descripción completa

Detalles Bibliográficos
Autores principales: Fibriani, Azzania, Taharuddin, Audrey Angelina Putri, Stephanie, Rebecca, Yamahoki, Nicholas, Laurelia, Jessica, Wisnuwardhani, Popi Hadi, Agustiyanti, Dian Fitria, Angelina, Marissa, Rubiyana, Yana, Ningrum, Ratih Asmana, Wardiana, Andri, Iskandar, Ferry, Permatasari, Fitri Aulia, Giri-Rachman, Ernawati Arifin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559838/
https://www.ncbi.nlm.nih.gov/pubmed/37809799
http://dx.doi.org/10.1016/j.heliyon.2023.e20089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559838/
https://www.ncbi.nlm.nih.gov/pubmed/37809799
http://dx.doi.org/10.1016/j.heliyon.2023.e20089

Ejemplares similares